: Israeli medtech company InMode’s stock up premarket after company offers guidance that tops estimates

InMode Ltd.’s stock INMD rose 2.5% premarket Wednesday, after the Israeli medical tech company offered second-quarter guidance that topped estimates and raised its full-year revenue guidance. The company said it expects second-quarter EPS of 70 cents to 71 cents on revenue of $135.7 million to $135.9 million. The FactSet consensus is for EPS of 64 cents and revenue of $130.0 million. For the full year, the company is expecting revenue to range from $530 million to $540 million, up from prior guidance of $525 million to $530 million. The FactSet consensus is for revenue of $531.6 million. The company will report second-quarter earnings on July 27. The stock has gained 14% in the year to date, while the S&P 500 SPXhas gained 16%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.